WallStreetZenWallStreetZen

NASDAQ: RPRX
Royalty Pharma Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Royalty Pharma revenue was $2.26B for the trailing 12 months ending Dec 31, 2024, with -24.4% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $593.6M, up 5.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RPRX annual revenue was $2.3B, with -3.9% growth year-over-year.

RPRX past revenue growth

How has RPRX's revenue growth performed historically?

Company
-3.86%
Industry
421.43%
Market
20.21%
RPRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RPRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RPRX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RPRX revenue history

Current Revenue
$2.3B
Current Earnings
$859.0M
Current Profit Margin
37.9%

Be the first to know when RPRX announces revenue.

RPRX Revenue History By Year

RPRX Yearly RevenueRPRX RevenueRPRX ChangeRPRX Revenue Growth
2024-12-31$2.26B-$90.98M-3.86%
2023-12-31$2.35B$117.34M+5.24%
2022-12-31$2.24B-$52.25M-2.28%
2021-12-31$2.29B$167.11M+7.87%
2020-12-31$2.12B$308.10M+16.98%
2019-12-31$1.81B$19.36M+1.08%
2018-12-31$1.79B$196.96M+12.33%
2017-12-31$1.60BN/AN/A

1 of 1

Royalty Pharma Revenue FAQ

What was RPRX's revenue last quarter?

On Invalid Date, Royalty Pharma (NASDAQ: RPRX) reported Q4 2024 revenue of $593.64 million up 0.41% year over year. In the same quarter last year, Royalty Pharma's revenue was $596.07 million.

What was Royalty Pharma's revenue in 2024?

Royalty Pharma's annual revenue for the twelve months ending Dec 31, 2024 was $2.26 billion, a 3.86% decrease year over year.

How much does Royalty Pharma make in a day?

Based on Royalty Pharma annual revenue for the past five years, RPRX makes an average of $6,173,786.85 per day.

What was Royalty Pharma's annual revenue growth in the past year?

As of Q1 2025, Royalty Pharma's revenue has grown -3.86% year over year. This is 425.3 percentage points lower than the US Biotechnology industry revenue growth rate of 421.43%. Royalty Pharma's revenue in the past year totaled $2.26 billion.

How much does Royalty Pharma make in a year?

Royalty Pharma's revenue by year for the past five years is:
  • Royalty Pharma's revenue for the twelve months ending Dec 31, 2024 was $2.26 billion, a 3.86% decrease year over year.
  • Royalty Pharma's annual revenue for Dec 31, 2023 was $2.35 billion, a 5.24% increase from 2022.
  • Royalty Pharma's annual revenue for 2022 was $2.24 billion, a 2.28% decrease from 2021.
  • Royalty Pharma's annual revenue for 2021 was $2.29 billion, a 7.87% increase from 2020.
  • Royalty Pharma's annual revenue for 2020 was $2.12 billion, a 16.98% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.